Clear Labs

Clear Labs has commercialized fully automated next-generation sequencing platforms for infectious disease surveillance—including FDA EUA-authorized COVID‑19 tests—and food safety applications. Their systems are used by public health labs across the US and internationally to accelerate pathogen detection with high accuracy. The company’s solutions have been validated by regulatory bodies such as AOAC International. Clear Labs stands out as a leading innovator in automating next-generation sequencing workflows for both infectious disease diagnostics/surveillance and food safety applications worldwide—a key player at the intersection of genomics technology and public/global health protection.